Review article: Influenza A (H1N1) virus in patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 1, 2010, Pages 5-10

  Rahier, J F ^a   Yazdanpanah, Y ^b   Viget, N ^b   Travis, S ^c   Colombel, J F ^a,d  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOMODULATING AGENT; METHOTREXATE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; PREDNISONE; ZANAMIVIR;

CHEMOPROPHYLAXIS; ENTERITIS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC; PHYSICIAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 71549157434     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04161.x     Document Type: Review

References (25)

1. Ginsberg M, Hopkins J, Maroufi A, et al. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Recomm Rep 2009 58 : 400 402.
2. Vaillant L, La Ruche G, Tarantola A, et al. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009 14 (33 Article 1.
3. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science, New York, NY 2009 324 : 1557 1561.
4. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006 12 : 894 899.
5. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006 19 : 571 582.
6. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New Engl J Med 2009 360 : 2605 2615.
7. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009 14 (34 Article 2.
8. European Center for Disease Prevention and Control (ECDC). Personal protective measures for reducing the risk of acquiring or transmitting human influenza. May 2009. Available at: http://ecdc.europa.eu/en/healthtopics/Pages/ Influenza-A(H1N1)-Personal-Protective-Measures.aspx.
9. Clark TW, Pareek M, Hoschler K, et al. Trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine - Preliminary Report. New Engl J Med 2009. [Epub ahead of print].
10. Greenberg ME, Lai MH, Hartel GF, et al. Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine - Preliminary Report. New Engl J Med 2009. [Epub ahead of print].
11. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2007 5 : 851 856.
12. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol 2009 104 : 444 453.
13. Brezinschek HP, Hofstaetter T, Leeb BF, et al. Immunization of patients with rheumatoid arthritis with antitumor necrosis factor alpha therapy and methotrexate. Curr Opin Rheumatol 2008 20 : 295 299.
14. Elkayam O, Bashkin A, Mandelboim M, et al. The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis. Semin Arthritis Rheum 2009 (doi :).
15. European Center for Disease Prevention and Control (ECDC). Use of specific pandemic influenza vaccines during H1N1 2009 pandemic. August 2009. Available at: http://ecdc.europa.eu/en/healthtopics/Documents/0908-Influenza- AH1N1-On-the-use-of-specific-pandemic-influenza-vaccines.pdf.
16. Morse D, Pickering L, Baker C, et al. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009 58 : 1 8.
17. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009 14 (31 Article 2.
18. Rahier JF, Ben-Horin S, Chowers Y, et al. on behalf of the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. JCC 2009 3 : 47 91.
19. Rahier JF, Yazdanpanah Y, Colombel JF, Travis SPL. The european consensus on the prevention of opportunistic infections in IBD: what does it change for the clinician? Gut 2009 58 : 1313 1315.
20. European Center for Disease Prevention and Control (ECDC). Public health use of influenza antivirals during influenza pandemics. August 2009. Available at: http://ecdc.europa.eu/en/publications/Publications/0907-GUI-Public-Health- use-of-Influenza-Antivirals-during-Influenza-Pandemic.pdf.
21. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005 353 : 1363 1373.
22. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000 283 : 1016 1024.
23. World Health Organization. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. August 2009. Available at: http://www.who.int/csr/resources/publications/swineflu/h1n1-use- antivirals-20090820/en/index.html.
24. Englund J, Zerr D, Heath J, et al. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington. MMWR Recomm Rep 2009 58 : 893 896.
25. Use of Oseltamivir in Patients Taking Methotrexate. June 2009. Available at: http://www.nelm.nhs.uk/en/Original-search/?query=tamiflu%2520methotrexate.